Agile Therapeutics Reports Third Quarter 2014 Financial Results
November 13, 2014 16:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Appoints James P. Tursi, M.D. to Its Board of Directors
October 01, 2014 16:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) announced today that James P. Tursi, M.D. has been appointed to the Company's Board of Directors effective...
Agile Announces Dosing of First Patients in Twirla(R) Phase 3 SECURE Study
September 29, 2014 07:59 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile to Present at the 21st Annual BioCentury NewsMakers Conference
September 22, 2014 07:59 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Initiates Phase 3 SECURE Study for Twirla(TM)
September 16, 2014 07:59 ET
|
Agile Therapeutics, Inc.
Twirla (AG200-15) is a Novel Low-Dose Combined Hormonal Contraceptive Patch Designed Using the Company's Proprietary Transdermal Skinfusion® Technology
Confirmatory SECURE...
Agile Therapeutics to Ring the NASDAQ Stock Market Closing Bell
September 02, 2014 07:59 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Reports Second Quarter 2014 Financial Results
August 14, 2014 16:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 14, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...